Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study if aspirin and statins (lipid-lowering agents) can
reduce the progression of subclinical atherosclerosis in patients with systemic lupus
erythematosus (SLE).